MPS
H1 FY27 was a record: revenue rose 17.8% to ₹448.5 Cr and EBITDA 39% to ₹154 Cr at a 34.3% margin, with zero debt. Q2 margin was also 34.3%.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every MPS earnings call we streamed: the live audio and our summary of what management said.
H1 FY27 was a record: revenue rose 17.8% to ₹448.5 Cr and EBITDA 39% to ₹154 Cr at a 34.3% margin, with zero debt. Q2 margin was also 34.3%.
H1 FY27 was a record: revenue rose 17.8% to ₹448.5 Cr and EBITDA 39% to ₹154 Cr at a 34.3% margin, with zero debt. Q2 margin was also 34.3%.
FY27 EBITDA floor raised to at least ₹310 Cr from 'comfortably above ₹300 Cr'. FY28 ₹1,500 Cr revenue target retained, including acquisitions.
MPS delivers record Q1 FY27 results, leveraging high operating leverage and AI integration to drive EBITDA growth significantly faster than revenue.
MPS Limited reports FY26 as its most profitable year, driven by AI-led knowledge solutions and the acquisition of Unbound Medicine.
MPS closed FY26 with record profitability, driven by its transformation into an AI-first knowledge solutions provider and the successful integration of Unbound Medicine.
MPS Limited reported record FY26 EPS of ₹102.11 (+16.3% YoY) with consolidated EBITDA of ₹236 Cr (30.7% margin), driven by an AI-first strategy and the Unbound Medicine acquisition.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.